{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T03:42:25Z","timestamp":1788838945944,"version":"build-2803163510"},"reference-count":270,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.sleep.2023.12.005","type":"journal-article","created":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T07:09:18Z","timestamp":1702710558000},"page":"378-396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Connecting the dots: An updated review of the role of autoimmunity in narcolepsy and emerging immunotherapeutic approaches"],"prefix":"10.1016","volume":"113","author":[{"given":"Parya","family":"Valizadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Momtazmanesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Plazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3836-1827","authenticated-orcid":false,"given":"Nima","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.sleep.2023.12.005_bib1","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00281-022-00933-9","article-title":"Narcolepsy: a model interaction between immune system, nervous system, and sleep-wake regulation","volume":"44","author":"Latorre","year":"2022","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.sleep.2023.12.005_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/792687","article-title":"Narcolepsy as an immune-mediated disease","volume":"2014","author":"De la Herr\u00e1n-Arita","year":"2014","journal-title":"Sleep Disord"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/sleep\/30.1.13","article-title":"The epidemiology of narcolepsy","volume":"30","author":"Longstreth","year":"2007","journal-title":"Sleep"},{"issue":"4","key":"10.1016\/j.sleep.2023.12.005_bib4","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","article-title":"Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib5","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1073\/pnas.95.1.322","article-title":"The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity","volume":"95","author":"De Lecea","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.sleep.2023.12.005_bib6","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/bies.1058","article-title":"Hypocretin\/orexin, sleep and narcolepsy","volume":"23","author":"Hungs","year":"2001","journal-title":"Bioessays"},{"issue":"1\u20132","key":"10.1016\/j.sleep.2023.12.005_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.neurol.2016.09.016","article-title":"French consensus. Type 1 and type 2 Narcolepsy: investigations and follow-up","volume":"173","author":"Monaca","year":"2017","journal-title":"Rev Neurol"},{"issue":"9","key":"10.1016\/j.sleep.2023.12.005_bib8","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41582-019-0226-9","article-title":"Narcolepsy \u2014 clinical spectrum, aetiopathophysiology, diagnosis and treatment","volume":"15","author":"Bassetti","year":"2019","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.5665\/sleep.2320","article-title":"Hypocretin deficiency develops during onset of human narcolepsy with cataplexy","volume":"36","author":"Savvidou","year":"2013","journal-title":"Sleep"},{"issue":"6","key":"10.1016\/j.sleep.2023.12.005_bib10","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.conb.2011.09.003","article-title":"Narcolepsy with hypocretin\/orexin deficiency, infections and autoimmunity of the brain","volume":"21","author":"Kornum","year":"2011","journal-title":"Curr Opin Neurobiol"},{"issue":"5","key":"10.1016\/j.sleep.2023.12.005_bib11","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1093\/brain\/awq086","article-title":"Narcolepsy: autoimmunity, effector T cell activation due to infection, or T cell independent, major histocompatibility complex class II induced neuronal loss?","volume":"133","author":"Fontana","year":"2010","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.sleep.2023.12.005_bib12","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.conb.2013.04.013","article-title":"The autoimmune basis of narcolepsy","volume":"23","author":"Mahlios","year":"2013","journal-title":"Curr Opin Neurobiol"},{"issue":"9","key":"10.1016\/j.sleep.2023.12.005_bib13","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1007\/s00415-018-8949-x","article-title":"Coexisting narcolepsy (with and without cataplexy) and multiple sclerosis : six new cases and a literature review","volume":"265","author":"Kallweit","year":"2018","journal-title":"J Neurol"},{"issue":"11","key":"10.1016\/j.sleep.2023.12.005_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.revmed.2010.10.352","article-title":"Narcolepsie r\u00e9v\u00e9lant un lupus \u00e9ryth\u00e9mateux syst\u00e9mique","volume":"32","author":"Haddad","year":"2011","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.sleep.2023.12.005_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155103","article-title":"Cytokines in narcolepsy: a systematic review and meta-analysis","volume":"131","author":"Mohammadi","year":"2020","journal-title":"Cytokine"},{"issue":"19","key":"10.1016\/j.sleep.2023.12.005_bib16","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2220911120","article-title":"Epigenetic silencing of selected hypothalamic neuropeptides in narcolepsy with cataplexy","volume":"120","author":"Seifinejad","year":"2023","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.sleep.2023.12.005_bib17","article-title":"Gut microbiome diversity is associated with sleep physiology in humans","volume":"14","author":"Smith","year":"2019"},{"issue":"6","key":"10.1016\/j.sleep.2023.12.005_bib18","doi-asserted-by":"crossref","first-page":"e896","DOI":"10.1212\/NXI.0000000000000896","article-title":"Gut microbiota composition is associated with narcolepsy type 1","volume":"7","author":"Lecomte","year":"2020","journal-title":"Neurol - Neuroimmunol Neuroinflammation"},{"key":"10.1016\/j.sleep.2023.12.005_bib19","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2147\/NSS.S275931","article-title":"Reviewing the clinical implications of treating narcolepsy as an autoimmune disorder","volume":"13","author":"Giannoccaro","year":"2021","journal-title":"Nat Sci Sleep"},{"issue":"8","key":"10.1016\/j.sleep.2023.12.005_bib20","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/BF01791317","article-title":"Epileptoide schlafzust\u00e4nde","author":"Fisher","year":"1878","journal-title":"Arch f\u00fcr Psychiatl"},{"issue":"7","key":"10.1016\/j.sleep.2023.12.005_bib21","first-page":"631","article-title":"Eigenth\u00fcmliche mit Einschl\u00e4fen verbundene Anf\u00e4lle","author":"Westphal","year":"1877","journal-title":"Arch Psychiatr Nervenkr"},{"issue":"53","key":"10.1016\/j.sleep.2023.12.005_bib22","first-page":"626","article-title":"De la narcolepsie","author":"G\u00e9lineau","year":"1880","journal-title":"Gaz des h\u00f4pitaux"},{"key":"10.1016\/j.sleep.2023.12.005_bib23","first-page":"1041","article-title":"Uber narkolepsie","volume":"49","author":"L\u00f6wenfeld","year":"1902","journal-title":"Uber Narkolepsie"},{"issue":"3","key":"10.1016\/j.sleep.2023.12.005_bib24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/00005053-193003000-00001","article-title":"Sleep as a problem of localization","volume":"71","author":"Economo","year":"1930","journal-title":"J Nerv Ment Dis"},{"issue":"4","key":"10.1016\/j.sleep.2023.12.005_bib25","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/archpsyc.1960.01710040091011","article-title":"Studies in psychophysiology of dreams","volume":"3","author":"Vogel","year":"1960","journal-title":"Arch Gen Psychiatr"},{"key":"10.1016\/j.sleep.2023.12.005_bib26","first-page":"488","article-title":"Studies on the relation of narcolepsy, cataplexy, and sleep with low voltage random EEG activity","volume":"vol. 45","author":"Rechtschaffen","year":"1967","journal-title":"Res Publ Assoc Res Nerv Ment Dis"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0013-4694(68)90060-6","article-title":"The nature of sleep attack and other symptoms of narcolepsy","volume":"24","author":"Hishikawa","year":"1968","journal-title":"Electroencephalogr Clin Neurophysiol"},{"issue":"4","key":"10.1016\/j.sleep.2023.12.005_bib28","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/sleep\/9.4.519","article-title":"Guidelines for the multiple sleep latency test (mslt): a standard measure of sleepiness","volume":"9","author":"Carskadon","year":"1986","journal-title":"Sleep"},{"issue":"5","key":"10.1016\/j.sleep.2023.12.005_bib29","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0013-4694(78)90162-1","article-title":"Excessive daytime sleepiness in man: multiple sleep latency measurement in narcoleptic and control subjects","volume":"45","author":"Richardson","year":"1978","journal-title":"Electroencephalogr Clin Neurophysiol"},{"issue":"12","key":"10.1016\/j.sleep.2023.12.005_bib30","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.2460\/javma.1973.162.12.1052","article-title":"Narcolepsy in a dog and a cat","volume":"162","author":"Knecht","year":"1973","journal-title":"J Am Vet Med Assoc"},{"issue":"2","key":"10.1016\/j.sleep.2023.12.005_bib31","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/0014-4886(74)90122-8","article-title":"Narcolepsy-cataplexy in a female dog","volume":"45","author":"Mitler","year":"1974","journal-title":"Exp Neurol"},{"issue":"4","key":"10.1016\/j.sleep.2023.12.005_bib32","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/sleep\/1.4.413","article-title":"Genetic factors in canine narcolepsy","volume":"1","author":"Foutz","year":"1978","journal-title":"Sleep"},{"issue":"3","key":"10.1016\/j.sleep.2023.12.005_bib33","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0014-4886(82)90038-3","article-title":"Canine model of narcolepsy: genetic and developmental determinants","volume":"75","author":"Baker","year":"1982","journal-title":"Exp Neurol"},{"issue":"2","key":"10.1016\/j.sleep.2023.12.005_bib34","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0031-9384(70)90061-2","article-title":"A pharmacological model of paradoxical sleep: the role of cholinergic and monoamine systems","volume":"5","author":"Karczmar","year":"1970","journal-title":"Physiol Behav"},{"key":"10.1016\/j.sleep.2023.12.005_bib35","first-page":"125","article-title":"[Research on the neural structures and responsible mechanisms in different phases of physiological sleep]","volume":"100","author":"Jouvet","year":"1962","journal-title":"Arch Ital Biol"},{"key":"10.1016\/j.sleep.2023.12.005_bib36","series-title":"Brain mechanisms of sleep","first-page":"199","article-title":"Canine narcolepsy-cataplexy syndrome: evidence for an inherited monoaminergic-cholinergic imbalance","author":"Baker","year":"1985"},{"issue":"4597","key":"10.1016\/j.sleep.2023.12.005_bib37","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1126\/science.6188216","article-title":"Narcolepsy: biogenic amine deficits in an animal model","volume":"220","author":"Mefford","year":"1983","journal-title":"Science (80-.)"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib38","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0006-8993(90)90328-9","article-title":"CNS monoamines and their metabolites in canine narcolepsy: a replication study","volume":"509","author":"Miller","year":"1990","journal-title":"Brain Res"},{"issue":"7","key":"10.1016\/j.sleep.2023.12.005_bib39","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1523\/JNEUROSCI.15-07-04806.1995","article-title":"Muscle atonia is triggered by cholinergic stimulation of the basal forebrain: implication for the pathophysiology of canine narcolepsy","volume":"15","author":"Nishino","year":"1995","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib40","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-8993(96)00541-0","article-title":"Local administration of dopaminergic drugs into the ventral tegmental area modulates cataplexy in the narcoleptic canine","volume":"733","author":"Reid","year":"1996","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib41","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1523\/JNEUROSCI.19-01-00248.1999","article-title":"Neuronal degeneration in canine narcolepsy","volume":"19","author":"Siegel","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.sleep.2023.12.005_bib42","first-page":"254","article-title":"Discrimination of narcolepsy by using genetic markers and HLA","volume":"12","author":"Honda","year":"1983","journal-title":"Sleep Res"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib43","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0987-7053(05)80279-5","article-title":"Autoimmune hypothesis in narcolepsy","volume":"23","author":"Carlander","year":"1993","journal-title":"Neurophysiol Clin Neurophysiol"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib44","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0960-5428(94)00043-N","article-title":"Narcolepsy and immunity","volume":"5","author":"Mignot","year":"1995","journal-title":"Adv Neuroimmunol"},{"issue":"6517","key":"10.1016\/j.sleep.2023.12.005_bib45","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1136\/bmj.292.6517.359","article-title":"Narcolepsy and immunity","volume":"292","author":"Parkes","year":"1986","journal-title":"BMJ"},{"issue":"8800","key":"10.1016\/j.sleep.2023.12.005_bib46","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/0140-6736(92)90571-J","article-title":"DQ (rather than DR) gene marks susceptibility to narcolepsy","volume":"339","author":"Matsuki","year":"1992","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.sleep.2023.12.005_bib47","first-page":"1012","article-title":"HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients","volume":"20","author":"Mignot","year":"1997","journal-title":"Sleep"},{"issue":"4","key":"10.1016\/j.sleep.2023.12.005_bib48","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1399-0039.1997.tb02761.x","article-title":"Extensive HLA class II studies in 58 non\u2010DRB1*15 (DR2) narcoleptic patients with cataplexy","volume":"49","author":"Mignot","year":"1997","journal-title":"Tissue Antigens"},{"issue":"suppl_8","key":"10.1016\/j.sleep.2023.12.005_bib49","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1093\/sleep\/17.suppl_8.S60","article-title":"DQB1*0602 and DQA1*0102 (DQ1) are better markers than DR2 for narcolepsy in caucasian and black Americans","volume":"17","author":"Mignot","year":"1994","journal-title":"Sleep"},{"issue":"Issue 2, Supplement 1","key":"10.1016\/j.sleep.2023.12.005_bib50","first-page":"S16","article-title":"Genetic and familial aspects of narcolepsy","volume":"50","author":"Mignot","year":"1998","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib51","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0198-8859(89)90067-0","article-title":"Narcolepsy without unique MHC class II antigen association: studies in the canine model","volume":"25","author":"Dean","year":"1989","journal-title":"Hum Immunol"},{"issue":"2","key":"10.1016\/j.sleep.2023.12.005_bib52","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/BF00395862","article-title":"Restriction fragment length polymorphism in canine narcolepsy","volume":"29","author":"Motoyama","year":"1989","journal-title":"Immunogenetics"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib53","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/geno.1999.5772","article-title":"Construction and characterization of an eightfold redundant dog genomic bacterial artificial chromosome library","volume":"58","author":"Li","year":"1999","journal-title":"Genomics"},{"issue":"3","key":"10.1016\/j.sleep.2023.12.005_bib54","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0092-8674(00)81965-0","article-title":"The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene","volume":"98","author":"Lin","year":"1999","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib55","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1073\/pnas.95.1.322","article-title":"The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity","volume":"95","author":"de Lecea","year":"1998","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"10.1016\/j.sleep.2023.12.005_bib56","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","article-title":"Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"issue":"1\u20132","key":"10.1016\/j.sleep.2023.12.005_bib57","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0006-8993(99)01336-0","article-title":"Distribution of orexin neurons in the adult rat brain","volume":"827","author":"Nambu","year":"1999","journal-title":"Brain Res"},{"issue":"23","key":"10.1016\/j.sleep.2023.12.005_bib58","doi-asserted-by":"crossref","first-page":"9996","DOI":"10.1523\/JNEUROSCI.18-23-09996.1998","article-title":"Neurons containing hypocretin (orexin) project to multiple neuronal systems","volume":"18","author":"Peyron","year":"1998","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.sleep.2023.12.005_bib59","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/(SICI)1096-9861(19991213)415:2<145::AID-CNE1>3.0.CO;2-2","article-title":"Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system","volume":"415","author":"Horvath","year":"1999","journal-title":"J Comp Neurol"},{"issue":"4","key":"10.1016\/j.sleep.2023.12.005_bib60","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0092-8674(00)81973-X","article-title":"Narcolepsy in orexin knockout mice","volume":"98","author":"Chemelli","year":"1999","journal-title":"Cell"},{"issue":"9197","key":"10.1016\/j.sleep.2023.12.005_bib61","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(99)05582-8","article-title":"Hypocretin (orexin) deficiency in human narcolepsy","volume":"355","author":"Nishino","year":"2000","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.sleep.2023.12.005_bib62","first-page":"207","article-title":"A hundred years of narcolepsy research","volume":"139","author":"Mignot","year":"2001","journal-title":"Arch Ital Biol"},{"issue":"4","key":"10.1016\/j.sleep.2023.12.005_bib63","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0013-4694(63)90032-4","article-title":"Nocturnal sleep of narcoleptics","volume":"15","author":"Rechtschaffen","year":"1963","journal-title":"Electroencephalogr Clin Neurophysiol"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib64","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1212\/WNL.16.1.18","article-title":"The nature of the narcoleptic sleep attack","volume":"16","author":"Dement","year":"1966","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.sleep.2023.12.005_bib65","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41583-018-0097-x","article-title":"The neurobiological basis of narcolepsy","volume":"20","author":"Mahoney","year":"2019","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.sleep.2023.12.005_bib66","article-title":"International classification of sleep disorders, 2nd edition: diagnostic and coding manual","author":"American academy of sleep medicine","year":"2005","journal-title":"Am Acad Sleep Med"},{"issue":"5","key":"10.1016\/j.sleep.2023.12.005_bib67","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1378\/chest.14-0970","article-title":"International classification of sleep disorders-Third Edition","volume":"146","author":"Sateia","year":"2014","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.sleep.2023.12.005_bib68","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1080\/03007995.2016.1208643","article-title":"The ICSD-3 and DSM-5 guidelines for diagnosing narcolepsy: clinical relevance and practicality","volume":"32","author":"Ruoff","year":"2016","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib69","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41598-018-36942-8","article-title":"HPLC analysis of CSF hypocretin-1 in type 1 and 2 narcolepsy","volume":"9","author":"Sakai","year":"2019","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.sleep.2023.12.005_bib70","first-page":"162","article-title":"[Narcolepsy as an autoimmune disease]","volume":"152","author":"Givaty","year":"2013","journal-title":"Harefuah"},{"issue":"3","key":"10.1016\/j.sleep.2023.12.005_bib71","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1750-3639.2003.tb00033.x","article-title":"Pattern of hypocretin (orexin) soma and axon loss, and gliosis, in human narcolepsy","volume":"13","author":"Thannickal","year":"2006","journal-title":"Brain Pathol"},{"issue":"3","key":"10.1016\/j.sleep.2023.12.005_bib72","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0896-6273(00)00058-1","article-title":"Reduced number of hypocretin neurons in human narcolepsy","volume":"27","author":"Thannickal","year":"2000","journal-title":"Neuron"},{"issue":"9","key":"10.1016\/j.sleep.2023.12.005_bib73","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/79690","article-title":"A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains","volume":"6","author":"Peyron","year":"2000","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.sleep.2023.12.005_bib74","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1212\/WNL.0b013e3181b2a6af","article-title":"Absence of ubiquitinated inclusions in hypocretin neurons of patients with narcolepsy","volume":"73","author":"Honda","year":"2009","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.sleep.2023.12.005_bib75","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1212\/01.WNL.0000142259.94107.4C","article-title":"In vivo evidence of neuronal loss in the hypothalamus of narcoleptic patients","volume":"63","author":"Lodi","year":"2004","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.sleep.2023.12.005_bib76","first-page":"195","article-title":"The hypocretin neuron system: an arousal system in the human brain","volume":"139","author":"Moore","year":"2001","journal-title":"Arch Ital Biol"},{"issue":"4","key":"10.1016\/j.sleep.2023.12.005_bib77","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0306-4522(98)00600-9","article-title":"Locus coeruleus neurons: cessation of activity during cataplexy","volume":"91","author":"Wu","year":"1999","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.sleep.2023.12.005_bib78","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2174\/187152709788921708","article-title":"Neuroimaging of narcolepsy","volume":"8","author":"Dang-Vu","year":"2009","journal-title":"CNS Neurol Disord - Drug Targets"},{"issue":"11","key":"10.1016\/j.sleep.2023.12.005_bib79","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/nm1102-1186","article-title":"Hypothalamic gray matter changes in narcoleptic patients","volume":"8","author":"Draganski","year":"2002","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.sleep.2023.12.005_bib80","first-page":"769","article-title":"Reduced hypothalamic gray matter in narcolepsy with cataplexy","volume":"27","author":"Buskova","year":"2006","journal-title":"Neuro Endocrinol Lett"},{"key":"10.1016\/j.sleep.2023.12.005_bib81","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neubiorev.2015.03.009","article-title":"Gray matter atrophy in narcolepsy: an activation likelihood estimation meta-analysis","volume":"59","author":"Weng","year":"2015","journal-title":"Neurosci Biobehav Rev"},{"issue":"8","key":"10.1016\/j.sleep.2023.12.005_bib82","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1212\/01.wnl.0000175219.01544.c8","article-title":"Narp immunostaining of human hypocretin (orexin) neurons: loss in narcolepsy","volume":"65","author":"Blouin","year":"2005","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.sleep.2023.12.005_bib83","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1212\/01.WNL.0000168173.71940.ab","article-title":"Concomitant loss of dynorphin, NARP, and orexin in narcolepsy","volume":"65","author":"Crocker","year":"2005","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.sleep.2023.12.005_bib84","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsaa278","article-title":"Animal models of narcolepsy and the hypocretin\/orexin system: past, present, and future","volume":"44","author":"Tisdale","year":"2021","journal-title":"Sleep"},{"issue":"11","key":"10.1016\/j.sleep.2023.12.005_bib85","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.2460\/javma.1976.168.11.1036","article-title":"Narcolepsy in seven dogs","volume":"168","author":"Mitler","year":"1976","journal-title":"J Am Vet Med Assoc"},{"issue":"5","key":"10.1016\/j.sleep.2023.12.005_bib86","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0013-4694(86)90078-7","article-title":"Evidence for excessive sleepiness in canine narcoleptics","volume":"64","author":"Kaitin","year":"1986","journal-title":"Electroencephalogr Clin Neurophysiol"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib87","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/sleep\/9.1.116","article-title":"Sleep fragmentation in canine narcolepsy","volume":"9","author":"Kaitin","year":"1986","journal-title":"Sleep"},{"issue":"2","key":"10.1016\/j.sleep.2023.12.005_bib88","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0896-6273(01)00293-8","article-title":"Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity","volume":"30","author":"Hara","year":"2001","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib89","article-title":"Bidirectional and context-dependent changes in theta and gamma oscillatory brain activity in noradrenergic cell-specific Hypocretin\/Orexin receptor 1-KO mice","volume":"8","author":"Li","year":"2018","journal-title":"Sci Rep"},{"issue":"19","key":"10.1016\/j.sleep.2023.12.005_bib90","doi-asserted-by":"crossref","first-page":"6495","DOI":"10.1523\/JNEUROSCI.0073-14.2014","article-title":"Conditional ablation of orexin\/hypocretin neurons: a new mouse model for the study of narcolepsy and orexin system function","volume":"34","author":"Tabuchi","year":"2014","journal-title":"J Neurosci"},{"issue":"5","key":"10.1016\/j.sleep.2023.12.005_bib91","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/brain\/awt069","article-title":"Electroencephalogram paroxysmal theta characterizes cataplexy in mice and children","volume":"136","author":"Vassalli","year":"2013","journal-title":"Brain"},{"issue":"35","key":"10.1016\/j.sleep.2023.12.005_bib92","doi-asserted-by":"crossref","first-page":"10939","DOI":"10.1523\/JNEUROSCI.1205-09.2009","article-title":"Sleep homeostasis modulates hypocretin-mediated sleep-to-wake transitions","volume":"29","author":"Carter","year":"2009","journal-title":"J Neurosci"},{"issue":"7168","key":"10.1016\/j.sleep.2023.12.005_bib93","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature06310","article-title":"Neural substrates of awakening probed with optogenetic control of hypocretin neurons","volume":"450","author":"Adamantidis","year":"2007","journal-title":"Nature"},{"issue":"39","key":"10.1016\/j.sleep.2023.12.005_bib94","doi-asserted-by":"crossref","first-page":"10956","DOI":"10.1073\/pnas.1603325113","article-title":"CD8 T cell-mediated killing of orexinergic neurons induces a narcolepsy-like phenotype in mice","volume":"113","author":"Bernard-Valnet","year":"2016","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"10.1016\/j.sleep.2023.12.005_bib95","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1093\/brain\/awab455","article-title":"Influenza vaccination induces autoimmunity against orexinergic neurons in a mouse model for narcolepsy","volume":"145","author":"Bernard-Valnet","year":"2022","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.sleep.2023.12.005_bib96","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s40263-017-0464-6","article-title":"Narcolepsy type 1 as an autoimmune disorder: evidence, and implications for pharmacological treatment","volume":"31","author":"Barateau","year":"2017","journal-title":"CNS Drugs"},{"issue":"10","key":"10.1016\/j.sleep.2023.12.005_bib97","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.5665\/sleep.4066","article-title":"HLA dqb1*06:02 negative narcolepsy with hypocretin\/orexin deficiency","volume":"37","author":"Han","year":"2014","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2023.12.005_bib98","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.sleep.2018.08.024","article-title":"Correlation between HLA-DQB1*06:02 and narcolepsy with and without cataplexy: approving a safe and sensitive genetic test in four major ethnic groups. A systematic meta-analysis","volume":"52","author":"Capittini","year":"2018","journal-title":"Sleep Med"},{"issue":"5","key":"10.1016\/j.sleep.2023.12.005_bib99","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1399-0039.1984.tb02144.x","article-title":"HLA antigens in Japanese patients with narcolepsy","volume":"24","author":"Juji","year":"1984","journal-title":"Tissue Antigens"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib100","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.humimm.2006.10.006","article-title":"DQB1*0301 and DQB1*0601 modulate narcolepsy susceptibility in Koreans","volume":"68","author":"Hong","year":"2007","journal-title":"Hum Immunol"},{"issue":"3","key":"10.1016\/j.sleep.2023.12.005_bib101","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1086\/318799","article-title":"Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups","volume":"68","author":"Mignot","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib102","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ajhg.2014.12.010","article-title":"HLA-DPB1 and HLA class I confer risk of and protection from narcolepsy","volume":"96","author":"Ollila","year":"2015","journal-title":"Am J Hum Genet"},{"issue":"9","key":"10.1016\/j.sleep.2023.12.005_bib103","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/ng.647","article-title":"Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy","volume":"42","author":"Hor","year":"2010","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib104","volume":"3","author":"Kornum","year":"2017","journal-title":"Narcolepsy. Nat Rev Dis Prim"},{"issue":"3","key":"10.1016\/j.sleep.2023.12.005_bib105","doi-asserted-by":"crossref","first-page":"581","DOI":"10.5665\/sleep.5532","article-title":"Narcolepsy-associated HLA class I alleles implicate cell-mediated cytotoxicity","volume":"39","author":"Tafti","year":"2016","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2023.12.005_bib106","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jaut.2013.02.003","article-title":"Genetic association, seasonal infections and autoimmune basis of narcolepsy","volume":"43","author":"Singh","year":"2013","journal-title":"J Autoimmun"},{"issue":"11","key":"10.1016\/j.sleep.2023.12.005_bib107","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/ng.231","article-title":"Variant between CPT1B and CHKB associated with susceptibility to narcolepsy","volume":"40","author":"Miyagawa","year":"2008","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.sleep.2023.12.005_bib108","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/ng.372","article-title":"Narcolepsy is strongly associated with the T-cell receptor alpha locus","volume":"41","author":"Hallmayer","year":"2009","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.sleep.2023.12.005_bib109","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.sleep.2011.06.020","article-title":"TCRA, P2RY11, and CPT1B\/CHKB associations in Chinese narcolepsy","volume":"13","author":"Han","year":"2012","journal-title":"Sleep Med"},{"issue":"3","key":"10.1016\/j.sleep.2023.12.005_bib110","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nri2938","article-title":"Immune cell regulation by autocrine purinergic signalling","volume":"11","author":"Junger","year":"2011","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"10.1016\/j.sleep.2023.12.005_bib111","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1093\/brain\/awx093","article-title":"Rare missense mutations in P2RY11 in narcolepsy with cataplexy","volume":"140","author":"Degn","year":"2017","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.sleep.2023.12.005_bib112","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1093\/hmg\/dds035","article-title":"Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy","volume":"21","author":"Winkelmann","year":"2012","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.sleep.2023.12.005_bib113","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/brain\/awv010","article-title":"Defects of mutant DNMT1 are linked to a spectrum of neurological disorders","volume":"138","author":"Baets","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.sleep.2023.12.005_bib114","article-title":"Genome wide analysis of narcolepsy in China implicates novel immune loci and reveals changes in association prior to versus after the 2009 H1N1 influenza pandemic","volume":"9","author":"Han","year":"2013"},{"key":"10.1016\/j.sleep.2023.12.005_bib115","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bbi.2015.05.003","article-title":"A polymorphism in CCR1\/CCR3 is associated with narcolepsy","volume":"49","author":"Toyoda","year":"2015","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.sleep.2023.12.005_bib116","article-title":"ImmunoChip study implicates antigen presentation to T cells in narcolepsy","volume":"9","author":"Faraco","year":"2013"},{"key":"10.1016\/j.sleep.2023.12.005_bib117","series-title":"The orexin\/hypocretin system","first-page":"341","article-title":"Narcolepsy and autoimmunity","author":"Taheri","year":"2006"},{"issue":"35","key":"10.1016\/j.sleep.2023.12.005_bib118","first-page":"111","article-title":"Narcolepsy patients have antibodies that stain distinct cell populations in rat brain and influence sleep patterns","author":"Bergman","year":"2014","journal-title":"Proc Natl Acad Sci"},{"issue":"9451","key":"10.1016\/j.sleep.2023.12.005_bib119","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(04)17553-3","article-title":"A functional autoantibody in narcolepsy","volume":"364","author":"Smith","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.sleep.2023.12.005_bib120","author":"Silber"},{"issue":"7","key":"10.1016\/j.sleep.2023.12.005_bib121","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/sleep\/33.7.875","article-title":"Anti-tribbles homolog 2 autoantibodies in Japanese patients with narcolepsy","volume":"33","author":"Toyoda","year":"2010","journal-title":"Sleep"},{"issue":"7","key":"10.1016\/j.sleep.2023.12.005_bib122","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/sleep\/33.7.869","article-title":"Anti-tribbles homolog 2 (TRIB2) autoantibodies in narcolepsy are associated with recent onset of cataplexy","volume":"33","author":"Kawashima","year":"2010","journal-title":"Sleep"},{"issue":"3","key":"10.1016\/j.sleep.2023.12.005_bib123","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1172\/JCI41366","article-title":"Elevated Tribbles homolog 2\u2013specific antibody levels in narcolepsy patients","volume":"120","author":"Cvetkovic-Lopes","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.sleep.2023.12.005_bib124","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaut.2013.06.010","article-title":"Passive transfer of narcolepsy: anti-TRIB2 autoantibody positive patient IgG causes hypothalamic orexin neuron loss and sleep attacks in mice","volume":"45","author":"Katzav","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.sleep.2023.12.005_bib125","article-title":"Anti-tribbles pseudokinase 2 (TRIB2)-Immunization modulates hypocretin\/orexin neuronal functions","year":"2016","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2023.12.005_bib126","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jaut.2015.07.006","article-title":"Autoantibodies against ganglioside GM3 are associated with narcolepsy-cataplexy developing after Pandemrix vaccination against 2009 pandemic H1N1 type influenza virus","volume":"63","author":"Saariaho","year":"2015","journal-title":"J Autoimmun"},{"issue":"3","key":"10.1016\/j.sleep.2023.12.005_bib127","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jsmc.2017.03.004","article-title":"The immune basis of narcolepsy","volume":"12","author":"Taheri","year":"2017","journal-title":"Sleep Med Clin"},{"issue":"294","key":"10.1016\/j.sleep.2023.12.005_bib128","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aab2354","article-title":"Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2","volume":"7","author":"Ahmed","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.sleep.2023.12.005_bib129","article-title":"Neuronal antibodies in children with or without narcolepsy following H1N1-AS03 vaccination","volume":"10","author":"Thebault","year":"2015"},{"key":"10.1016\/j.sleep.2023.12.005_bib130","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2013.2831","article-title":"Hypothalamic immunopathology in anti-ma\u2013associated diencephalitis with narcolepsy-cataplexy","author":"Dauvilliers","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.sleep.2023.12.005_bib131","article-title":"Narcolepsy type 1 is associated with a systemic increase and activation of regulatory T cells and with a systemic activation of global T cells","volume":"12","author":"Lecendreux","year":"2017"},{"issue":"8","key":"10.1016\/j.sleep.2023.12.005_bib132","article-title":"High nocturnal sleep fragmentation is associated with low T lymphocyte P2Y11 protein levels in narcolepsy type 1","volume":"44","author":"Viste","year":"2021","journal-title":"Sleep [Internet]"},{"issue":"3","key":"10.1016\/j.sleep.2023.12.005_bib133","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsw070","article-title":"CD4+ T-cell reactivity to orexin\/hypocretin in patients with narcolepsy type 1","volume":"40","author":"Ramberger","year":"2017","journal-title":"Sleep"},{"issue":"7","key":"10.1016\/j.sleep.2023.12.005_bib134","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1084\/jem.20090504","article-title":"Human naive and memory CD4+ T cell repertoires specific for naturally processed antigens analyzed using libraries of amplified T cells","volume":"206","author":"Geiger","year":"2009","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib135","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1600-065X.2012.01140.x","article-title":"T\u2010cell trafficking in the central nervous system","volume":"248","author":"Sallusto","year":"2012","journal-title":"Immunol Rev"},{"issue":"7725","key":"10.1016\/j.sleep.2023.12.005_bib136","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41586-018-0540-1","article-title":"T cells in patients with narcolepsy target self-antigens of hypocretin neurons","volume":"562","author":"Latorre","year":"2018","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib137","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.sleep.2003.06.002","article-title":"Factors associated with a delay in the diagnosis of narcolepsy","volume":"5","author":"Morrish","year":"2004","journal-title":"Sleep Med"},{"issue":"2","key":"10.1016\/j.sleep.2023.12.005_bib138","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.immuni.2017.01.007","article-title":"Dysregulation of the cytokine GM-CSF induces spontaneous phagocyte invasion and immunopathology in the central nervous system","volume":"46","author":"Spath","year":"2017","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.sleep.2023.12.005_bib139","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.immuni.2018.11.002","article-title":"Are neuropeptide-reactive T cells behind narcolepsy?","volume":"49","author":"Deerhake","year":"2018","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib140","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/s41467-019-08774-1","article-title":"CD8+ T cells from patients with narcolepsy and healthy controls recognize hypocretin neuron-specific antigens","volume":"10","author":"Pedersen","year":"2019","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.sleep.2023.12.005_bib141","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1084\/jem.20160897","article-title":"High-dimensional single-cell analysis reveals the immune signature of narcolepsy","volume":"213","author":"Hartmann","year":"2016","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib142","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/nyas.12793","article-title":"Type 1 narcolepsy: a CD8 + T cell-mediated disease?","volume":"1351","author":"Degn","year":"2015","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib143","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.nbd.2003.09.003","article-title":"Excitotoxic degeneration of hypothalamic orexin neurons in slice culture","volume":"15","author":"Katsuki","year":"2004","journal-title":"Neurobiol Dis"},{"issue":"11","key":"10.1016\/j.sleep.2023.12.005_bib144","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1097\/00001756-200508010-00005","article-title":"Quinolinic acid toxicity on orexin neurons blocked by gamma aminobutyric acid type A receptor stimulation","volume":"16","author":"Katsuki","year":"2005","journal-title":"Neuroreport"},{"issue":"5","key":"10.1016\/j.sleep.2023.12.005_bib145","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.neuron.2006.04.032","article-title":"Tandem-pore K+ channels mediate inhibition of orexin neurons by glucose","volume":"50","author":"Burdakov","year":"2006","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.sleep.2023.12.005_bib146","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.2353\/ajpath.2009.080897","article-title":"Interferon-\u03b3 prevents death of bystander neurons during CD8 T cell responses in the brain","volume":"174","author":"Richter","year":"2009","journal-title":"Am J Pathol"},{"issue":"8","key":"10.1016\/j.sleep.2023.12.005_bib147","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1089\/ars.2007.1511","article-title":"Neuronal apoptosis in neurodegeneration","volume":"9","author":"Okouchi","year":"2007","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"10.1016\/j.sleep.2023.12.005_bib148","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1096\/fasebj.5.2.1825981","article-title":"Functional diversity of T lymphocytes due to secretion of different cytokine patterns","volume":"5","author":"Street","year":"1991","journal-title":"FASEB J"},{"issue":"3","key":"10.1016\/j.sleep.2023.12.005_bib149","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ni1558","article-title":"A mechanism for the initiation of allergen-induced T helper type 2 responses","volume":"9","author":"Sokol","year":"2008","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.sleep.2023.12.005_bib150","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.sleep.2011.10.023","article-title":"Post H1N1 vaccination narcolepsy\u2013cataplexy with decreased CSF beta-amyloid","volume":"13","author":"Kallweit","year":"2012","journal-title":"Sleep Med"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib151","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11325-015-1305-9","article-title":"Beta-amyloid and phosphorylated tau metabolism changes in narcolepsy over time","volume":"20","author":"Liguori","year":"2016","journal-title":"Sleep Breath"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib152","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/glia.440070110","article-title":"Microglial involvement in experimental autoimmune inflammation of the central and peripheral nervous system","volume":"7","author":"Gehrmann","year":"1993","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib153","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jneuroim.2008.06.034","article-title":"MHC class II exacerbates demyelination in vivo independently of T cells","volume":"203","author":"Hiremath","year":"2008","journal-title":"J Neuroimmunol"},{"issue":"6","key":"10.1016\/j.sleep.2023.12.005_bib154","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/iub.208","article-title":"Structural immunology and crystallography help immunologists see the immune system in action: how T and NK cells touch their ligands","volume":"61","author":"Chen","year":"2009","journal-title":"IUBMB Life"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib155","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/glia.440070114","article-title":"Microglia in degenerative neurological disease","volume":"7","author":"McGeer","year":"1993","journal-title":"Glia"},{"issue":"15","key":"10.1016\/j.sleep.2023.12.005_bib156","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1523\/JNEUROSCI.16-15-04588.1996","article-title":"Major histocompatibility class II molecules in the CNS: increased microglial expression at the onset of narcolepsy in a canine model","volume":"16","author":"Tafti","year":"1996","journal-title":"J Neurosci"},{"issue":"1\u20132","key":"10.1016\/j.sleep.2023.12.005_bib157","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.brainres.2004.06.016","article-title":"Effects of inflammation produced by chronic lipopolysaccharide administration on the survival of hypocretin neurons and sleep","volume":"1019","author":"Gerashchenko","year":"2004","journal-title":"Brain Res"},{"issue":"2","key":"10.1016\/j.sleep.2023.12.005_bib158","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0301-0082(00)00032-0","article-title":"Kynurenines in the CNS: from endogenous obscurity to therapeutic importance","volume":"64","author":"Stone","year":"2001","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.sleep.2023.12.005_bib159","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2014.00120","article-title":"Histamine: a new immunomodulatory player in the neuron-glia crosstalk","volume":"8","author":"Rocha","year":"2014","journal-title":"Front Cell Neurosci"},{"issue":"2","key":"10.1016\/j.sleep.2023.12.005_bib160","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0304-3940(91)90559-C","article-title":"Murine brain macrophages induce NMDA receptor mediated neurotoxicity in vitro by secreting glutamate","volume":"133","author":"Piani","year":"1991","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.sleep.2023.12.005_bib161","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bbi.2020.11.038","article-title":"Glutaminase in microglia: a novel regulator of neuroinflammation","volume":"92","author":"Ding","year":"2021","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.sleep.2023.12.005_bib162","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bbi.2013.01.002","article-title":"Central inhibition of interleukin-6 trans-signaling during peripheral infection reduced neuroinflammation and sickness in aged mice","volume":"30","author":"Burton","year":"2013","journal-title":"Brain Behav Immun"},{"issue":"6","key":"10.1016\/j.sleep.2023.12.005_bib163","doi-asserted-by":"crossref","first-page":"R994","DOI":"10.1152\/ajpregu.1984.246.6.R994","article-title":"Sleep-promoting effects of endogenous pyrogen (interleukin-1)","volume":"246","author":"Krueger","year":"1984","journal-title":"Am J Physiol Integr Comp Physiol"},{"issue":"3","key":"10.1016\/j.sleep.2023.12.005_bib164","doi-asserted-by":"crossref","first-page":"R708","DOI":"10.1152\/ajpregu.1992.263.3.R708","article-title":"Somnogenic, pyrogenic, and anorectic activities of tumor necrosis factor-alpha and TNF-alpha fragments","volume":"263","author":"Kapas","year":"1992","journal-title":"Am J Physiol Integr Comp Physiol"},{"key":"10.1016\/j.sleep.2023.12.005_bib165","unstructured":"Krueger JM, Obal F, Opp M, Toth L, Johannsen L, Cady AB. Somnogenic cytokines and models concerning their effects on sleep. Yale J Biol Med [Internet]. 63(2):157\u2013172. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2205056."},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib166","doi-asserted-by":"crossref","first-page":"R151","DOI":"10.1152\/ajpregu.1994.266.1.R151","article-title":"Inhibition of nitric oxide synthesis suppresses sleep in rabbits","volume":"266","author":"Kapas","year":"1994","journal-title":"Am J Physiol Integr Comp Physiol"},{"issue":"1\u20132","key":"10.1016\/j.sleep.2023.12.005_bib167","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0006-8993(94)91969-0","article-title":"Inhibition of nitric oxide synthesis inhibits rat sleep","volume":"664","author":"Kap\u00e1s","year":"1994","journal-title":"Brain Res"},{"key":"10.1016\/j.sleep.2023.12.005_bib168","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bbi.2015.03.004","article-title":"Cerebrospinal fluid cytokine levels in type 1 narcolepsy patients very close to onset","volume":"49","author":"Kornum","year":"2015","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.sleep.2023.12.005_bib169","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jaut.2015.03.003","article-title":"Impact of cytokine in type 1 narcolepsy: role of pandemic H1N1 vaccination","volume":"60","author":"Lecendreux","year":"2015","journal-title":"J Autoimmun"},{"key":"10.1016\/j.sleep.2023.12.005_bib170","author":"Schoenborn"},{"key":"10.1016\/j.sleep.2023.12.005_bib171","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.bbi.2013.12.019","article-title":"Cerebrospinal fluid and serum cytokine profiles in narcolepsy with cataplexy: a case-control study","volume":"37","author":"Dauvilliers","year":"2014","journal-title":"Brain Behav Immun"},{"issue":"4","key":"10.1016\/j.sleep.2023.12.005_bib172","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nm0496-449","article-title":"Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia","volume":"2","author":"Garcia-Zepeda","year":"1996","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib173","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.clim.2014.04.012","article-title":"From airway inflammation to inflammatory bowel disease: eotaxin-1, a key regulator of intestinal inflammation","volume":"153","author":"Adar","year":"2014","journal-title":"Clin Immunol"},{"issue":"8","key":"10.1016\/j.sleep.2023.12.005_bib174","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/sleep\/32.8.979","article-title":"Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset","volume":"32","author":"Aran","year":"2009","journal-title":"Sleep"},{"issue":"10","key":"10.1016\/j.sleep.2023.12.005_bib175","doi-asserted-by":"crossref","first-page":"a016295","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"2","key":"10.1016\/j.sleep.2023.12.005_bib176","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0014-5793(89)80476-4","article-title":"Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes","volume":"242","author":"Castell","year":"1989","journal-title":"FEBS Lett"},{"key":"10.1016\/j.sleep.2023.12.005_bib177","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.brainres.2012.01.061","article-title":"Central nervous system inflammation in disease related conditions: mechanistic prospects","volume":"1446","author":"Fung","year":"2012","journal-title":"Brain Res"},{"key":"10.1016\/j.sleep.2023.12.005_bib178","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2019.00892","article-title":"Cytokine alterations in schizophrenia: an updated review","volume":"10","author":"Momtazmanesh","year":"2019","journal-title":"Front Psychiatry"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib179","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0960-5428(94)00047-R","article-title":"Sleep as a neuroimmune phenomenon: a brief historical perspective","volume":"5","author":"Krueger","year":"1995","journal-title":"Adv Neuroimmunol"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib180","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1742-2094-11-51","article-title":"Inflammation-sleep interface in brain disease: TNF, insulin, orexin","volume":"11","author":"Clark","year":"2014","journal-title":"J Neuroinflammation"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib181","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1749-6632.1998.tb08323.x","article-title":"Sleep: a physiologic role for IL\u20101\u03b2 and TNF\u2010\u03b1 a","volume":"856","author":"Krueger","year":"1998","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib182","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.biopsych.2015.05.014","article-title":"Sleep disturbance, sleep duration, and inflammation: a systematic review and meta-analysis of cohort studies and experimental sleep deprivation","volume":"80","author":"Irwin","year":"2016","journal-title":"Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.sleep.2023.12.005_bib183","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3109\/15622970109027498","article-title":"Alterations of host defence system after sleep deprivation are followed by impaired mood and psychosocial functioning","volume":"2","author":"Heiser","year":"2001","journal-title":"World J Biol Psychiatr"},{"issue":"10","key":"10.1016\/j.sleep.2023.12.005_bib184","first-page":"3597","article-title":"Effects of sleep and sleep deprivation on interleukin-6, growth hormone, cortisol, and melatonin levels in humans 1","volume":"85","author":"Redwine","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.sleep.2023.12.005_bib185","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.bbi.2003.11.002","article-title":"Exploring the cytokine and endocrine involvement in narcolepsy","volume":"18","author":"Okun","year":"2004","journal-title":"Brain Behav Immun"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib186","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0889-8529(01)00005-6","article-title":"Sleep, the hypothalamic\u2013pituitary\u2013adrenal axis, and cytokines: multiple interactions and disturbances in sleep disorders","volume":"31","author":"Vgontzas","year":"2002","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"5","key":"10.1016\/j.sleep.2023.12.005_bib187","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1210\/jcem.82.5.3950","article-title":"Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity","volume":"82","author":"Vgontzas","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.sleep.2023.12.005_bib188","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1210\/jcem.84.8.5894","article-title":"Circadian interleukin-6 secretion and quantity and depth of sleep","volume":"84","author":"Vgontzas","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib189","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13148-016-0254-x","article-title":"Identification of a methylation profile for DNMT1-associated autosomal dominant cerebellar ataxia, deafness, and narcolepsy","volume":"8","author":"Kernohan","year":"2016","journal-title":"Clin Epigenetics"},{"issue":"7","key":"10.1016\/j.sleep.2023.12.005_bib190","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.5664\/jcsm.9198","article-title":"Narcolepsy type 1 features across the life span: age impact on clinical and polysomnographic phenotype","volume":"17","author":"Lividini","year":"2021","journal-title":"J Clin Sleep Med"},{"issue":"7","key":"10.1016\/j.sleep.2023.12.005_bib191","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1080\/15592294.2019.1603962","article-title":"Circulating levels of inflammatory markers and DNA methylation, an analysis of repeated samples from a population based cohort","volume":"14","author":"Myte","year":"2019","journal-title":"Epigenetics"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib192","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.fertnstert.2007.06.008","article-title":"Prolonged stimulation with tumor necrosis factor-\u03b1 induced partial methylation at PR-B promoter in immortalized epithelial-like endometriotic cells","volume":"90","author":"Wu","year":"2008","journal-title":"Fertil Steril"},{"issue":"8","key":"10.1016\/j.sleep.2023.12.005_bib193","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1002\/ppul.25512","article-title":"Narcolepsy in Children: sleep disorders in children, A rapidly evolving field seeking consensus","volume":"57","author":"Dye","year":"2022","journal-title":"Pediatr Pulmonol"},{"issue":"1-Part-I","key":"10.1016\/j.sleep.2023.12.005_bib194","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1365-2869.2009.00756.x","article-title":"Medical exposures in youth and the frequency of narcolepsy with cataplexy: a population-based case-control study in genetically predisposed people","volume":"19","author":"Koepsell","year":"2010","journal-title":"J Sleep Res"},{"issue":"3","key":"10.1016\/j.sleep.2023.12.005_bib195","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/ana.22587","article-title":"Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China","volume":"70","author":"Han","year":"2011","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.sleep.2023.12.005_bib196","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S1474-4422(14)70075-4","article-title":"Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination","volume":"13","author":"Partinen","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.sleep.2023.12.005_bib197","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2014.01.033","article-title":"Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants","volume":"50","author":"Ahmed","year":"2014","journal-title":"J Autoimmun"},{"issue":"4","key":"10.1016\/j.sleep.2023.12.005_bib198","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/ana.23799","article-title":"Decreased incidence of childhood narcolepsy 2 years after the 2009 H1N1 winter flu pandemic","volume":"73","author":"Han","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.sleep.2023.12.005_bib199","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.smrv.2017.06.006","article-title":"Incidence of narcolepsy after H1N1 influenza and vaccinations: systematic review and meta-analysis","volume":"38","author":"Sarkanen","year":"2018","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.sleep.2023.12.005_bib200","article-title":"Risk of narcolepsy associated with inactivated adjuvanted (AS03) A\/H1N1 (2009) Pandemic influenza vaccine in Quebec","volume":"9","author":"Montplaisir","year":"2014"},{"key":"10.1016\/j.sleep.2023.12.005_bib201","article-title":"Antigenic differences between AS03 adjuvanted influenza A (H1N1) pandemic vaccines: implications for pandemrix-associated narcolepsy risk","volume":"9","author":"Vaarala","year":"2014"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib202","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1038\/s41598-021-83543-z","article-title":"A\/H1N1 hemagglutinin antibodies show comparable affinity in vaccine-related Narcolepsy type 1 and control and are unlikely to contribute to pathogenesis","volume":"11","author":"Lind","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.sleep.2023.12.005_bib203","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.sleep.2023.04.024","article-title":"Association between hypersomnolence and the COVID-19 pandemic: the international COVID-19 sleep study (ICOSS)","volume":"107","author":"Sarkanen","year":"2023","journal-title":"Sleep Med"},{"issue":"8","key":"10.1016\/j.sleep.2023.12.005_bib204","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1001\/jamaneurol.2020.2065","article-title":"Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019","volume":"77","author":"Zubair","year":"2020","journal-title":"JAMA Neurol"},{"issue":"9","key":"10.1016\/j.sleep.2023.12.005_bib205","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1111\/ene.14277","article-title":"Does SARS\u2010Cov\u20102 invade the brain? Translational lessons from animal models","volume":"27","author":"Natoli","year":"2020","journal-title":"Eur J Neurol"},{"issue":"5","key":"10.1016\/j.sleep.2023.12.005_bib206","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/mds.28084","article-title":"SARS\u2010CoV\u20102: at the crossroad between aging and neurodegeneration","volume":"35","author":"Lippi","year":"2020","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2023.12.005_bib207","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bbi.2020.03.031","article-title":"Nervous system involvement after infection with COVID-19 and other coronaviruses","volume":"87","author":"Wu","year":"2020","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.sleep.2023.12.005_bib208","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.mehy.2019.03.017","article-title":"The olfactory bulb: a link between environmental agents and narcolepsy","volume":"126","author":"Mori","year":"2019","journal-title":"Med Hypotheses"},{"issue":"4","key":"10.1016\/j.sleep.2023.12.005_bib209","doi-asserted-by":"crossref","first-page":"338","DOI":"10.4149\/av_2015_04_338","article-title":"Transolfactory neuroinvasion by viruses threatens the human brain","volume":"59","author":"Mori","year":"2015","journal-title":"Acta Virol"},{"issue":"7","key":"10.1016\/j.sleep.2023.12.005_bib210","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1128\/JVI.78.7.3398-3406.2004","article-title":"Coronavirus neurovirulence correlates with the ability of the virus to induce proinflammatory cytokine signals from astrocytes and microglia","volume":"78","author":"Li","year":"2004","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.sleep.2023.12.005_bib211","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.sleep.2010.07.004","article-title":"Olfactory dysfunction in narcolepsy with cataplexy","volume":"11","author":"Bayard","year":"2010","journal-title":"Sleep Med"},{"issue":"9","key":"10.1016\/j.sleep.2023.12.005_bib212","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.molmed.2022.06.005","article-title":"Olfactory dysfunction in COVID-19: pathology and long-term implications for brain health","volume":"28","author":"Doty","year":"2022","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.sleep.2023.12.005_bib213","doi-asserted-by":"crossref","DOI":"10.3389\/fnana.2012.00044","article-title":"Hypothalamus-olfactory system crosstalk: orexin A immunostaining in mice","volume":"6","author":"Gascuel","year":"2012","journal-title":"Front Neuroanat"},{"issue":"4","key":"10.1016\/j.sleep.2023.12.005_bib214","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00415-020-10131-y","article-title":"COVID-19: dealing with a potential risk factor for chronic neurological disorders","volume":"268","author":"Schirinzi","year":"2021","journal-title":"J Neurol"},{"key":"10.1016\/j.sleep.2023.12.005_bib215","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.sleep.2022.06.011","article-title":"Reactogenic sleepiness after COVID-19 vaccination. A hypothesis involving orexinergic system linked to inflammatory signals","volume":"98","author":"Garrido-Su\u00e1rez","year":"2022","journal-title":"Sleep Med"},{"issue":"10","key":"10.1016\/j.sleep.2023.12.005_bib216","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.5664\/jcsm.10134","article-title":"Pfizer\/BioNTech SARS-CoV-2 vaccine as a potential trigger for the development of narcolepsy: a case report","volume":"18","author":"Mahamid","year":"2022","journal-title":"J Clin Sleep Med"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib217","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13099-019-0332-7","article-title":"Is there any association between gut microbiota and type 1 diabetes? A systematic review","volume":"11","author":"Jamshidi","year":"2019","journal-title":"Gut Pathog"},{"issue":"10","key":"10.1016\/j.sleep.2023.12.005_bib218","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1080\/14737175.2019.1638763","article-title":"Microbiota-gut brain axis involvement in neuropsychiatric disorders","volume":"19","author":"Iannone","year":"2019","journal-title":"Expert Rev Neurother"},{"issue":"3","key":"10.1016\/j.sleep.2023.12.005_bib219","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/ana.24901","article-title":"The gut microbiome in human neurological disease: a review","volume":"81","author":"Tremlett","year":"2017","journal-title":"Ann Neurol"},{"issue":"39","key":"10.1016\/j.sleep.2023.12.005_bib220","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v20.i39.14105","article-title":"Irritable bowel syndrome: a microbiome-gut-brain axis disorder?","volume":"20","author":"Kennedy","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.sleep.2023.12.005_bib221","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cell.2015.02.047","article-title":"Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis","volume":"161","author":"Yano","year":"2015","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib222","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12967-017-1175-y","article-title":"Influence of diet on the gut microbiome and implications for human health","volume":"15","author":"Singh","year":"2017","journal-title":"J Transl Med"},{"issue":"2","key":"10.1016\/j.sleep.2023.12.005_bib223","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3390\/microorganisms7020041","article-title":"Potential role for the gut microbiota in modulating host circadian rhythms and metabolic health","volume":"7","author":"Parkar","year":"2019","journal-title":"Microorganisms"},{"key":"10.1016\/j.sleep.2023.12.005_bib224","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.brainres.2018.03.015","article-title":"Neurotransmitter modulation by the gut microbiota","volume":"1693","author":"Strandwitz","year":"2018","journal-title":"Brain Res"},{"key":"10.1016\/j.sleep.2023.12.005_bib225","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mib.2016.10.003","article-title":"Microbiome, metabolites and host immunity","volume":"35","author":"Levy","year":"2017","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.sleep.2023.12.005_bib226","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.2147\/NSS.S330022","article-title":"Gut Microbiota in Patients with Type 1 Narcolepsy","volume":"13","author":"Zhang","year":"2021","journal-title":"Nat Sci Sleep"},{"issue":"9211","key":"10.1016\/j.sleep.2023.12.005_bib227","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S0140-6736(05)74704-8","article-title":"Increased body-mass index in patients with narcolepsy","volume":"355","author":"Schuld","year":"2000","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.sleep.2023.12.005_bib228","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/cns.12105","article-title":"Impact of obesity in children with narcolepsy","volume":"19","author":"Inocente","year":"2013","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.sleep.2023.12.005_bib229","article-title":"Looking for a signal in the noise: revisiting obesity and the microbiome","volume":"7","author":"Sze","year":"2016"},{"issue":"11","key":"10.1016\/j.sleep.2023.12.005_bib230","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s00415-007-0594-8","article-title":"Response to intravenous immunoglobulins and placebo in a patient with narcolepsy with cataplexy","volume":"254","author":"Fronczek","year":"2007","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib231","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.transci.2016.12.017","article-title":"Mechanisms of action of intravenous immunoglobulin","volume":"56","author":"Chaigne","year":"2017","journal-title":"Transfus Apher Sci"},{"issue":"16","key":"10.1016\/j.sleep.2023.12.005_bib232","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1212\/WNL.0b013e3181bd1344","article-title":"Normalization of hypocretin-1 in narcolepsy after intravenous immunoglobulin treatment","volume":"73","author":"Dauvilliers","year":"2009","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.sleep.2023.12.005_bib233","doi-asserted-by":"crossref","first-page":"441","DOI":"10.5664\/jcsm.6500","article-title":"Intravenous immunoglobulin therapy in pediatric narcolepsy: a nonrandomized, open-label, controlled, longitudinal observational study","volume":"13","author":"Lecendreux","year":"2017","journal-title":"J Clin Sleep Med"},{"issue":"5","key":"10.1016\/j.sleep.2023.12.005_bib234","doi-asserted-by":"crossref","first-page":"e389","DOI":"10.1212\/NXI.0000000000000389","article-title":"Long-term improvement after combined immunomodulation in early post-H1N1 vaccination narcolepsy","volume":"4","author":"Viste","year":"2017","journal-title":"Neurol - Neuroimmunol Neuroinflammation"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib235","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1212\/WNL.0b013e31825dce03","article-title":"Early IVIg treatment has no effect on post-H1N1 narcolepsy phenotype or hypocretin deficiency","volume":"79","author":"Knudsen","year":"2012","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.sleep.2023.12.005_bib236","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/NRL.0000000000000099","article-title":"Transient impact of rituximab in H1N1 vaccination\u2013associated narcolepsy with severe psychiatric symptoms","volume":"21","author":"Sarkanen","year":"2016","journal-title":"Neurologist"},{"issue":"6","key":"10.1016\/j.sleep.2023.12.005_bib237","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/ana.20339","article-title":"Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset","volume":"56","author":"Dauvilliers","year":"2004","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib238","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ana.20892","article-title":"Follow-up of four narcolepsy patients treated with intravenous immunoglobulins","volume":"60","author":"Dauvilliers","year":"2006","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.sleep.2023.12.005_bib239","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1055\/s-0030-1267993","article-title":"Intravenous immunoglobulin treatment and screening for hypocretin neuron-specific autoantibodies in recent onset childhood narcolepsy with cataplexy","volume":"41","author":"Knudsen","year":"2010","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.sleep.2023.12.005_bib240","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2019.577111","article-title":"Positive oligoclonal bands and CSF pleocytosis in narcolepsy type 1: a case report supporting the immune-mediated hypothesis","volume":"339","author":"Moreno-Est\u00e9banez","year":"2020","journal-title":"J Neuroimmunol"},{"issue":"10","key":"10.1016\/j.sleep.2023.12.005_bib241","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s00415-008-0983-7","article-title":"Intravenous high-dose immunoglobulin treatment in recent onset childhood narcolepsy with cataplexy","volume":"255","author":"Plazzi","year":"2008","journal-title":"J Neurol"},{"key":"10.1016\/j.sleep.2023.12.005_bib242","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/1671072","article-title":"Intravenous immunoglobulin therapy administered early after narcolepsy type 1 onset in three patients evaluated by clinical and polysomnographic follow-up","volume":"2018","author":"Ruppert","year":"2018","journal-title":"Behav Neurol"},{"issue":"12","key":"10.1016\/j.sleep.2023.12.005_bib243","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1007\/s00415-008-0996-2","article-title":"No persistent effect of intravenous immunoglobulins in patients with narcolepsy with cataplexy","volume":"255","author":"Valko","year":"2008","journal-title":"J Neurol"},{"issue":"1\u20133","key":"10.1016\/j.sleep.2023.12.005_bib244","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2741\/1249","article-title":"Pharmacologic immunosuppression","volume":"9","author":"Barshes","year":"2004","journal-title":"Front Biosci"},{"issue":"2A","key":"10.1016\/j.sleep.2023.12.005_bib245","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1590\/S0004-282X2007000200028","article-title":"Report of two narcoleptic patients with remission of hypersomnolence following use of prednisone","volume":"65","author":"Coelho","year":"2007","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.sleep.2023.12.005_bib246","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.sleep.2016.01.024","article-title":"Steroid therapy ameliorated cataplexy in three children with recent-onset of narcolepsy","volume":"29","author":"Miyata","year":"2017","journal-title":"Sleep Med"},{"issue":"4","key":"10.1016\/j.sleep.2023.12.005_bib247","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2869.2003.00380.x","article-title":"Clinical efficacy of high-dose intravenous immunoglobulins near the onset of narcolepsy in a 10-year-old boy","volume":"12","author":"Lecendreux","year":"2003","journal-title":"J Sleep Res"},{"issue":"5","key":"10.1016\/j.sleep.2023.12.005_bib248","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1210\/jc.2004-1056","article-title":"On the interactions of the hypothalamic-pituitary-adrenal (HPA) Axis and sleep: normal HPA Axis activity and circadian rhythm, exemplary sleep disorders","volume":"90","author":"Buckley","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.sleep.2023.12.005_bib249","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/sleep\/34.3.349","article-title":"Abnormally low serum acylcarnitine levels in narcolepsy patients","volume":"34","author":"Miyagawa","year":"2011","journal-title":"Sleep"},{"issue":"7","key":"10.1016\/j.sleep.2023.12.005_bib250","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/sleep\/26.7.809","article-title":"Report of a case of immunosuppression with prednisone in an 8-year-old boy with an acute onset of hypocretin-deficiency narcolepsy","volume":"26","author":"Hecht","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2023.12.005_bib251","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.sleep.2017.02.014","article-title":"Comorbidity of narcolepsy with cataplexy and transverse myelitis: a common autoimmune background? A case report","volume":"33","author":"Peraita-Adrados","year":"2017","journal-title":"Sleep Med"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib252","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11940-020-0609-7","article-title":"Immunotherapy in narcolepsy","volume":"22","author":"Giannoccaro","year":"2020","journal-title":"Curr Treat Options Neurol"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib253","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s11325-020-02034-z","article-title":"Treatment with immune modulators in a child with recent-onset type 1 narcolepsy","volume":"25","author":"Ding","year":"2021","journal-title":"Sleep Breath"},{"issue":"7","key":"10.1016\/j.sleep.2023.12.005_bib254","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/imj.14349","article-title":"Anti\u2010Ma2\u2010associated paraneoplastic encephalitis eat, sleep and repeat","volume":"49","author":"Peters","year":"2019","journal-title":"Intern Med J"},{"issue":"6","key":"10.1016\/j.sleep.2023.12.005_bib255","doi-asserted-by":"crossref","first-page":"e613","DOI":"10.1212\/NXI.0000000000000613","article-title":"CSF orexin-A levels after rituximab treatment in recent onset narcolepsy type 1","volume":"6","author":"Wasling","year":"2019","journal-title":"Neurol - Neuroimmunol Neuroinflammation"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib256","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/1756285614563522","article-title":"Alemtuzumab in the treatment of multiple sclerosis: key clinical trial results and considerations for use","volume":"8","author":"Havrdova","year":"2015","journal-title":"Ther Adv Neurol Disord"},{"issue":"4","key":"10.1016\/j.sleep.2023.12.005_bib257","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2869.2011.00985.x","article-title":"A remarkable effect of alemtuzumab in a patient suffering from narcolepsy with cataplexy","volume":"21","author":"Donjacour","year":"2012","journal-title":"J Sleep Res"},{"issue":"2","key":"10.1016\/j.sleep.2023.12.005_bib258","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2147\/tcrm.2007.3.2.259","article-title":"Natalizumab: a new treatment for relapsing remitting multiple sclerosis","volume":"3","author":"Hutchinson","year":"2007","journal-title":"Therapeut Clin Risk Manag"},{"key":"10.1016\/j.sleep.2023.12.005_bib259","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2015.00018","article-title":"Improvement in fatigue during natalizumab treatment is linked to improvement in depression and day-time sleepiness","volume":"6","author":"Penner","year":"2015","journal-title":"Front Neurol"},{"issue":"4","key":"10.1016\/j.sleep.2023.12.005_bib260","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7224\/1537-2073.2015-033","article-title":"NAPS-MS","volume":"18","author":"Sater","year":"2016","journal-title":"Int J MS Care"},{"issue":"7","key":"10.1016\/j.sleep.2023.12.005_bib261","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsaa050","article-title":"Treatment of narcolepsy with natalizumab","volume":"43","author":"Scammell","year":"2020","journal-title":"Sleep"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib262","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/1744-9987.13663","article-title":"Performance, clinical effectiveness, and safety of immunoadsorption in a wide range of indications","volume":"26","author":"Fuchs","year":"2022","journal-title":"Ther Apher Dial"},{"issue":"6","key":"10.1016\/j.sleep.2023.12.005_bib263","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s10072-008-1036-9","article-title":"Immunoadsorption for the treatment of narcolepsy with cataplexy","volume":"29","author":"Pincherle","year":"2008","journal-title":"Neurol Sci"},{"issue":"3","key":"10.1016\/j.sleep.2023.12.005_bib264","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/ana.20603","article-title":"Late-onset narcolepsy presenting as rapidly progressing muscle weakness: response to plasmapheresis","volume":"58","author":"Chen","year":"2005","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.sleep.2023.12.005_bib265","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/archneurol.2011.56","article-title":"Narcolepsy, REM sleep behavior disorder, and supranuclear gaze palsy associated with Ma1 and Ma2 antibodies and tonsillar carcinoma","volume":"68","author":"Adams","year":"2011","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1016\/j.sleep.2023.12.005_bib266","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1215\/S1152851702000467","article-title":"Paraneoplastic limbic encephalitis and possible narcolepsy in a patient with testicular cancer: case study","volume":"5","author":"Landolfi","year":"2003","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/j.sleep.2023.12.005_bib267","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.pediatrneurol.2012.12.038","article-title":"Narcolepsy with cataplexy as presenting symptom of occult neuroblastoma","volume":"49","author":"Sinsioco","year":"2013","journal-title":"Pediatr Neurol"},{"issue":"11","key":"10.1016\/j.sleep.2023.12.005_bib268","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nrclinonc.2009.146","article-title":"Cyclophosphamide and cancer: golden anniversary","volume":"6","author":"Emadi","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"10.1016\/j.sleep.2023.12.005_bib269","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00281-011-0245-0","article-title":"Immunomodulatory effects of cyclophosphamide and implementations for vaccine design","volume":"33","author":"Sistigu","year":"2011","journal-title":"Semin Immunopathol"},{"issue":"4","key":"10.1016\/j.sleep.2023.12.005_bib270","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00280-016-3152-1","article-title":"The effect of cyclophosphamide on the immune system: implications for clinical cancer therapy","volume":"78","author":"Ahlmann","year":"2016","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945723015691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945723015691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T15:45:35Z","timestamp":1761407135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945723015691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":270,"alternative-id":["S1389945723015691"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2023.12.005","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Connecting the dots: An updated review of the role of autoimmunity in narcolepsy and emerging immunotherapeutic approaches","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2023.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}